phenylmethylsulfonyl fluoride has been researched along with arachidonyl-2-chloroethylamide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breitenbucher, JG; Seierstad, M | 1 |
Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ | 1 |
Andres-Mach, M; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Dudra-Jastrzebska, M; Luszczki, JJ | 1 |
Andres-Mach, M; Barcicka-Klosowska, B; Florek-Luszczki, M; Haratym-Maj, A; Luszczki, JJ; Zolkowska, D | 1 |
Andres-Mach, M; Chmielewski, J; Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Patrzylas, P; Szpringer, M; Zagaja, M; Zaluska, K | 1 |
1 review(s) available for phenylmethylsulfonyl fluoride and arachidonyl-2-chloroethylamide
Article | Year |
---|---|
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Topics: Amidohydrolases; Animals; Drug Discovery; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship | 2008 |
4 other study(ies) available for phenylmethylsulfonyl fluoride and arachidonyl-2-chloroethylamide
Article | Year |
---|---|
Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Topics: Amidohydrolases; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Enzyme Inhibitors; Forelimb; Male; Memory; Mice; Molecular Structure; Muscles; Phenylmethylsulfonyl Fluoride; Receptor, Cannabinoid, CB1; Seizures; Time Factors; Valproic Acid | 2006 |
Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Disease Models, Animal; Drug Combinations; Electroshock; Enzyme Inhibitors; Male; Memory Disorders; Mice; Muscle Strength; Muscle, Skeletal; Phenylmethylsulfonyl Fluoride; Psychomotor Performance; Receptor, Cannabinoid, CB1; Seizures | 2010 |
Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hand Strength; Male; Mice; Motor Activity; Pentylenetetrazole; Phenylmethylsulfonyl Fluoride; Seizures | 2012 |
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobazam; Cornea; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy, Complex Partial; Lacosamide; Levetiracetam; Male; Mice; Muscle Strength; Nipecotic Acids; Phenobarbital; Phenylmethylsulfonyl Fluoride; Piracetam; Psychomotor Performance; Receptor, Cannabinoid, CB1; Tiagabine; Valproic Acid | 2017 |